Form 4 for SUPN SUPERNUS PHARMACEUTICALS, INC.
Accepted 2026-03-10 00:00:00 ET · period of report 2026-03-06 · accession 0002117599-26-000004 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2026-03-10 | 2026-03-09+ | SUPN | Horich William Todd | SVP, Commercial Ops | S - Sale+OE | $54.50 | -8,877 | 0 | -100% | -$483.8K |
| DM | 2026-03-10 | 2026-03-06 | SUPN | Horich William Todd | SVP, Commercial Ops | F - Tax | $54.73 | -3,455 | 6,241 | -36% | -$189.1K |
| DM | 2026-03-10 | 2026-03-06 | SUPN | Horich William Todd | SVP, Commercial Ops | M - OptEx | $0.00 | +7,500 | 7,457 | New | $0 |
| DM | 2026-03-10 | 2026-03-06 | SUPN | Horich William Todd | SVP, Commercial Ops | M - OptEx | $0.00 | -7,500 | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-03-09 | S | D | 4,438 | $54.00 | 4,439 | D | — | — | |
| 2 | Common | Common Stock | 2026-03-06 | F | D | 521 | $54.73 | 8,877 | D | — | — | |
| 3 | Common | Common Stock | 2026-03-06 | M | A | 1,125 | $0.00 | 9,398 | D | — | — | |
| 4 | Common | Common Stock | 2026-03-06 | F | D | 1,718 | $54.73 | 8,273 | D | — | — | |
| 5 | Common | Common Stock | 2026-03-06 | M | A | 3,750 | $0.00 | 9,991 | D | — | — | |
| 6 | Common | Common Stock | 2026-03-06 | F | D | 1,216 | $54.73 | 6,241 | D | — | — | |
| 7 | Common | Common Stock | 2026-03-10 | S | D | 4,439 | $55.00 | 0 | D | — | — | |
| 8 | Common | Common Stock | 2026-03-06 | M | A | 2,625 | $0.00 | 7,457 | D | — | — | |
| 9 | Derivative | Performance Share Unit | 2026-03-06 | M | D | 1,125 | $0.00 | 0 | D | $0.00 · — to — | 1,125 Common Stock | (F2) On February 22, 2024, the Reporting Person was awarded Performance Share Units, a portion of which vested upon the achievement of individual performance objectives within a defined performance period, which objectives were established on June 24, 2024. |
| 10 | Derivative | Performance Share Unit | 2026-03-06 | M | D | 2,625 | $0.00 | 0 | D | $0.00 · — to — | 2,625 Common Stock | (F2) On February 22, 2024, the Reporting Person was awarded Performance Share Units, a portion of which vested upon the achievement of individual performance objectives within a defined performance period, which objectives were established on June 24, 2024. |
| 11 | Derivative | Performance Share Unit | 2026-03-06 | M | D | 3,750 | $0.00 | 0 | D | $0.00 · — to — | 3,750 Common Stock | (F2) On February 22, 2024, the Reporting Person was awarded Performance Share Units, a portion of which vested upon the achievement of individual performance objectives within a defined performance period, which objectives were established on June 24, 2024. |